SelectX Pharmaceuticals Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

SelectX Pharmaceuticals General Information

Description

Developer of a drug discovery platform designed to focus on the discovery and development of aminoglycoside therapeutics. The company's platform develops small-molecule antimicrobials and other therapeutics for unmet medical needs through the application of genetic technology, enabling medical companies to develop effective compounds for anti-infective and other therapeutic applications.

Contact Information

Formerly Known As
OmniScience Pharmaceuticals
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 607 Boylston Street
  • Lower Level
  • Boston, MA 02116
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 607 Boylston Street
  • Lower Level
  • Boston, MA 02116
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SelectX Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 31-Oct-2023 Completed Generating Revenue
4. Secondary Transaction - Private 01-Mar-2022 Completed Generating Revenue
3. Early Stage VC (Series B) 23-Dec-2003 Completed Generating Revenue
2. Early Stage VC (Series A) $2.5M $2.5M Completed Startup
1. Merger of Equals 20-Sep-2002 Completed Startup
To view SelectX Pharmaceuticals’s complete valuation and funding history, request access »

SelectX Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view SelectX Pharmaceuticals’s complete cap table history, request access »

SelectX Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug discovery platform designed to focus on the discovery and development of aminoglycoside therapeutics
Drug Discovery
Boston, MA
5 As of 2021

Cambridge, MA
 

Lund, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SelectX Pharmaceuticals Competitors (34)

One of SelectX Pharmaceuticals’s 34 competitors is Vedanta Biosciences, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vedanta Biosciences Venture Capital-Backed Cambridge, MA
BioInvent International Formerly VC-backed Lund, Sweden
BioXcel Therapeutics Formerly VC-backed New Haven, CT
AtaiBeckley Formerly VC-backed New York, NY
Alector Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 34 competitors. Get the full list »

SelectX Pharmaceuticals Patents

SelectX Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2847203-A1 4,6-substituted 2,5-dideoxystreptamine aminoglycoside antibiotics Inactive 03-Feb-2012
US-20130203693-A1 4,6-substituted 2,5-dideoxystreptamine aminoglycoside antibiotics Active 03-Feb-2012
US-8586552-B2 4,6-substituted 2,5-dideoxystreptamine aminoglycoside antibiotics Inactive 03-Feb-2012
WO-2013116480-A1 4,6-substituted 2,5-dideoxystreptamine aminoglycoside antibiotics Inactive 03-Feb-2012
US-20030228623-A1 For rapid production of diverse populations of selectable compounds as well as ready selection from such populations of small molecules attached to display peptides that bind target molecules or have desired activities (e.g. antibiotics); drugs Inactive 28-Sep-2001 C40B40/02
To view SelectX Pharmaceuticals’s complete patent history, request access »

SelectX Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SelectX Pharmaceuticals Acquisitions (2)

SelectX Pharmaceuticals’s most recent deal was a Merger/Acquisition with BioChemist. The deal was made on 20-Sep-2002.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BioChemist 20-Sep-2002 Merger/Acquisition Other Pharmaceuticals and Biotechnology
OmniScience Pharmaceuticals 20-Sep-2002 Merger/Acquisition Drug Discovery
To view SelectX Pharmaceuticals’s complete acquisitions history, request access »

SelectX Pharmaceuticals FAQs

  • When was SelectX Pharmaceuticals founded?

    SelectX Pharmaceuticals was founded in 2002.

  • Where is SelectX Pharmaceuticals headquartered?

    SelectX Pharmaceuticals is headquartered in Boston, MA.

  • What is the size of SelectX Pharmaceuticals?

    SelectX Pharmaceuticals has 5 total employees.

  • What industry is SelectX Pharmaceuticals in?

    SelectX Pharmaceuticals’s primary industry is Drug Discovery.

  • Is SelectX Pharmaceuticals a private or public company?

    SelectX Pharmaceuticals is a Private company.

  • What is SelectX Pharmaceuticals’s current revenue?

    The current revenue for SelectX Pharmaceuticals is .

  • How much funding has SelectX Pharmaceuticals raised over time?

    SelectX Pharmaceuticals has raised $10.5M.

  • Who are SelectX Pharmaceuticals’s competitors?

    Vedanta Biosciences, BioInvent International, BioXcel Therapeutics, AtaiBeckley, and Alector are some of the 34 competitors of SelectX Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process